Balanced news tone
News Sentiment
A1ZN34 sentiment intelligence
AstraZeneca PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
93/100 classification confidence.
directly relevant articles
high-authority source matches
-12.3% over one week, -3.4% over four weeks, trend inactive, and near fair-value range.
HSBC Cuts AstraZeneca to Hold Amid Trial Setbacks and Uncertain Catalysts
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
HSBC Cuts AstraZeneca to Hold Amid Trial Setbacks and Uncertain Catalysts
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 13 Jul 2026 11:57
- Source
- StockInvest.us
AstraZeneca and Ionis’ stocks drop significantly on Wainua ATTR-CM trial failure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 15:59
- Source
- Clinical Trials Arena
AstraZeneca sees stock market value slump by more than £20bn after drug setback
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 09 Jul 2026 10:39
- Source
- Asian Image
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Yahoo! Finance Canada
‘Pfizer and AstraZeneca were ABANDONED, yet…': Sen Johnson drops bombshell on COVID vaccine injuries
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- The Economic Times
AstraZeneca shares drop after US regulators vote against breast cancer drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Reuters
AstraZeneca shares rise to top of FTSE 100 as COPD drug clears two pivotal trials
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Proactive financial news
AstraZeneca stock jumps as COPD drug trial win surprises market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Invezz
Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory | LSE:AZN, NASDAQ:AZN
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Feb 2026 08:00
- Source
- Proactive financial news
AstraZeneca charts a blockbuster path to growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- The Armchair Trader
NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- PR Newswire UK
15 stocks to watch: Lupin, Ola, AstraZeneca, Shriram Finance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Dec 2025 08:00
- Source
- BusinessLine
AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2023 07:00
- Source
- AstraZeneca
Brazil suspends use of AstraZeneca vaccine in pregnant women nationally after death
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2021 07:00
- Source
- Reuters
Brazil Approves Emergency Use of Sinovac, AstraZeneca Shots
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jan 2021 08:00
- Source
- Bloomberg.com
India's Serum Institute reportedly seeks emergency use for AstraZeneca's Covid vaccine
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Dec 2020 08:00
- Source
- CNBC
Why AstraZeneca’s reward for Covid vaccine is a share price slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Nov 2020 08:00
- Source
- The Guardian